CJ
Therapeutic Areas
Peijia Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TaurusNXT TAVR System | Aortic Stenosis/Regurgitation | Pre-market (NMPA under review) |
| GeminiOne TEER System | Mitral Regurgitation | Pre-market (NMPA under review) |
| MonarQ TTVR System | Tricuspid Regurgitation | Global Clinical Trial |
| TaurusTrio TAVR System | Aortic Regurgitation | Pre-market (NMPA approved 2025) |
| ReachTact Robotic System | Robotic-assisted TAVR | Early Clinical |